Unstable angina non ST elevation myocardial infarction cost-effectiveness of therapy: Difference between revisions
YazanDaaboul (talk | contribs) No edit summary |
m (Bot: Removing from Primary care) |
||
Line 13: | Line 13: | ||
==References== | ==References== | ||
{{Reflist|2}} | {{Reflist|2}} | ||
{{WH}} | |||
{{WS}} | |||
[[Category:Ischemic heart diseases]] | [[Category:Ischemic heart diseases]] | ||
Line 23: | Line 25: | ||
[[Category:Up-To-Date cardiology]] | [[Category:Up-To-Date cardiology]] | ||
[[Category:Needs content]] | [[Category:Needs content]] | ||
Revision as of 00:33, 30 July 2020
Resident Survival Guide |
Unstable angina / NSTEMI Microchapters |
Differentiating Unstable Angina/Non-ST Elevation Myocardial Infarction from other Disorders |
Special Groups |
Diagnosis |
Laboratory Findings |
Treatment |
Antitplatelet Therapy |
Additional Management Considerations for Antiplatelet and Anticoagulant Therapy |
Risk Stratification Before Discharge for Patients With an Ischemia-Guided Strategy of NSTE-ACS |
Mechanical Reperfusion |
Discharge Care |
Case Studies |
Unstable angina non ST elevation myocardial infarction cost-effectiveness of therapy On the Web |
FDA on Unstable angina non ST elevation myocardial infarction cost-effectiveness of therapy |
CDC onUnstable angina non ST elevation myocardial infarction cost-effectiveness of therapy |
Unstable angina non ST elevation myocardial infarction cost-effectiveness of therapy in the news |
Blogs on Unstable angina non ST elevation myocardial infarction cost-effectiveness of therapy |
Please help WikiDoc by adding content here. It's easy! Click here to learn about editing.